FCAS
MDGL icon

First Command Advisory Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

First Command Advisory Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5
Closed -$1.66K – 640
2025
Q1 		$1.66K Buy
+5
New +$1.64K ﹤0.01% 498

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

First Command Advisory Services's MDGL Position: Q2 2025 in Review

First Command Advisory Services sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2025, closing a stake of 5 shares — an estimated $1.66K sold.

First Command Advisory Services first reported a position in MDGL in Q1 2025 and held it in 1 quarter. The position peaked at $1.66K in Q1 2025. 305 funds tracked by Wall St. Rank hold MDGL as of Q2 2025.

  • First Command Advisory Services reported no remaining Madrigal Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • First Command Advisory Services sold 5 Madrigal Pharmaceuticals shares in Q2 2025, an estimated $1.66K.
  • First Command Advisory Services first reported a position in Madrigal Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • First Command Advisory Services's Madrigal Pharmaceuticals position peaked at $1.66K in Q1 2025.
  • 305 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2025.

Based on First Command Advisory Services's 13F filing for Q2 2025, filed 1 Aug 2025.